Literature DB >> 20199405

Common wound colonizers in patients with epidermolysis bullosa.

Heather A Brandling-Bennett1, Kimberly D Morel.   

Abstract

One of the major morbidities of patients with epidermolysis bullosa is the tendency to develop chronic wounds, which predisposes them to multiple complications including life-threatening infections, failure to thrive, and squamous cell carcinomas. Chronic wounds frequently become colonized with bacteria, and we sought to identify the most common microorganisms isolated on cultures from patients with epidermolysis bullosa. We conducted a retrospective review of positive wound, nasal, and blood cultures, including bacterial, fungal and viral, in 30 patients with epidermolysis bullosa. Staphylococcus sp., Streptococcus sp., diptheroids, Pseudomonas aeruginosa, and Candida sp. were the most commonly isolated microorganisms in wound cultures from our epidermolysis bullosa patients. Two patients had viral cultures that grew herpes simplex virus type-1. Bacterial colonization of chronic wounds can lead to infections and may also impact wound healing. Results from this study provide data on which to base empiric antibiotic choice in patients with epidermolysis bullosa when needed and may be useful in planning strategies for decolonization and improved wound healing in this population.

Entities:  

Mesh:

Year:  2010        PMID: 20199405     DOI: 10.1111/j.1525-1470.2009.01070.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  10 in total

1.  IgG4 subclass-specific responses to Staphylococcus aureus antigens shed new light on host-pathogen interaction.

Authors:  Jasper Swierstra; Stephanie Debets; Corné de Vogel; Nicole Lemmens-den Toom; Nelianne Verkaik; Nadjia Ramdani-Bouguessa; Marcel F Jonkman; Jan Maarten van Dijl; Ahmed Fahal; Alex van Belkum; Willem van Wamel
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

2.  From the wound to the bench: exoproteome interplay between wound-colonizing Staphylococcus aureus strains and co-existing bacteria.

Authors:  Andrea N García-Pérez; Anne de Jong; Sabryna Junker; Dörte Becher; Monika A Chlebowicz; José C Duipmans; Marcel F Jonkman; Jan Maarten van Dijl
Journal:  Virulence       Date:  2018-01-01       Impact factor: 5.882

3.  Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study).

Authors:  Amy S Paller; John Browning; Milos Nikolic; Christine Bodemer; Dedee F Murrell; Willistine Lenon; Eva Krusinska; Allen Reha; Hjalmar Lagast; Jay A Barth
Journal:  Orphanet J Rare Dis       Date:  2020-06-23       Impact factor: 4.123

4.  Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes.

Authors:  Christina Guttmann-Gruber; Birgit Tockner; Cornelia Scharler; Clemens Hüttner; John E Common; Angeline S L Tay; Simon L I J Denil; Alfred Klausegger; Andrea Trost; Jenny Breitenbach; Peter Schnitzhofer; Peter Hofbauer; Martin Wolkersdorfer; Anja Diem; Martin Laimer; Dirk Strunk; Johann W Bauer; Julia Reichelt; Roland Lang; Josefina Piñón Hofbauer
Journal:  Sci Rep       Date:  2018-09-07       Impact factor: 4.379

Review 5.  Epidermolysis bullosa: Advances in research and treatment.

Authors:  Christine Prodinger; Julia Reichelt; Johann W Bauer; Martin Laimer
Journal:  Exp Dermatol       Date:  2019-08-08       Impact factor: 3.960

Review 6.  Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex.

Authors:  Nadezhda A Evtushenko; Arkadii K Beilin; Anastasiya V Kosykh; Ekaterina A Vorotelyak; Nadya G Gurskaya
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

7.  T-cell activation and bacterial infection in skin wounds of recessive dystrophic epidermolysis bullosa patients.

Authors:  Vitali Alexeev; Leonie Huitema; Taylor Phillips; Rodrigo Cepeda; Diego de Los Cobos; Regina Isabella Matus Perez; Mauricio Salas-Garza; Oscar R Fajardo-Ramirez; Franziska Ringpfeil; Jouni Uitto; Julio Cesar Salas-Alanis; Olga Igoucheva
Journal:  Exp Dermatol       Date:  2022-06-06       Impact factor: 4.511

8.  Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database.

Authors:  Laura E Levin; Leila H Shayegan; Anne W Lucky; Kristen P Hook; Anna L Bruckner; James A Feinstein; Susan Whittier; Christine T Lauren; Elena Pope; Irene Lara-Corrales; Karen Wiss; Catherine C McCuaig; Julie Powell; Lawrence F Eichenfield; Moise L Levy; Lucia Diaz; Sharon A Glick; Amy S Paller; Harper N Price; John C Browning; Kimberly D Morel
Journal:  Pediatr Dermatol       Date:  2020-11-28       Impact factor: 1.588

Review 9.  Immunological mechanisms underlying progression of chronic wounds in recessive dystrophic epidermolysis bullosa.

Authors:  Leonie Huitema; Taylor Phillips; Vitali Alexeev; Olga Igoucheva
Journal:  Exp Dermatol       Date:  2021-06-27       Impact factor: 4.511

Review 10.  Intracellular escape strategies of Staphylococcus aureus in persistent cutaneous infections.

Authors:  Leonie Huitema; Taylor Phillips; Vitali Alexeev; Marjana Tomic-Canic; Irena Pastar; Olga Igoucheva
Journal:  Exp Dermatol       Date:  2020-11-21       Impact factor: 4.511

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.